J&J | JNJ - Sales Revenues



J&J reported $23.74B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AbbVie USD 15.42B 2.08B Jun/2025
Abbott USD 11.42B 1.06B Jun/2025
Amgen USD 9.18B 1.03B Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Biogen USD 2.6B 170M Jun/2025
Boston Scientific USD 5.06B 400M Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
CONMED USD 342.34M 21.04M Jun/2025
Cooper Companies USD 1.06B 60.3M Jul/2025
Dexcom USD 1.16B 120M Jun/2025
Edwards Lifesciences USD 1.53B 120M Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Globus Medical USD 745.3M 147.2M Jun/2025
Hologic USD 1.02B 10M Jun/2025
Insulet USD 649.1M 80.1M Jun/2025
Integra LifeSciences USD 415.6M 32.9M Jun/2025
Intuitive Surgical USD 2.44B 190M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Medtronic USD 8.6B 330M Jun/2025
Merck USD 15.81B 280M Jun/2025
Merit Medical Systems USD 382.5M 27.1M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Regeneron Pharmaceuticals USD 3.68B 650M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.99B 90M Jun/2025
Stryker USD 6.02B 120M Jun/2025
Tandem Diabetes Care USD 240.68M 6.28M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025
Zimmer Biomet Holdings USD 2.08B 170M Jun/2025
Zoetis USD 2.46B 240M Jun/2025